Review article · 2024 · Open access
Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
Cancers, 16(8), 1589 · Published 20 April 2024 · DOI 10.3390/cancers16081589
In brief
“Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer” is a 2024 review article by Xin Gu and Tamara Minko, published in Cancers. OpenAlex counts 72 citations as of 21 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Cancers.
- Citations
- 72
- Most cited in
- 2025 (31)
- Field-weighted impact
- 1.62
- References
- 260
- Authors
- 2
Abstract
Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest cancers, presents significant challenges in diagnosis and treatment due to its aggressive, metastatic nature and lack of early detection methods. A key obstacle in PDAC treatment is the highly complex tumor environment characterized by dense stroma surrounding the tumor, which hinders effective drug delivery. Nanotechnology can offer innovative solutions to these challenges, particularly in creating novel drug delivery systems for existing anticancer drugs for PDAC, such as gemcitabine and paclitaxel. By using customization methods such as incorporating conjugated targeting ligands, tumor-penetrating peptides, and therapeutic nucleic acids, these nanoparticle-based systems enhance drug solubility, extend circulation time, improve tumor targeting, and control drug release, thereby minimizing side effects and toxicity in healthy tissues. Moreover, nanoparticles have also shown potential in precise diagnostic methods for PDAC. This literature review will delve into targeted mechanisms, pathways, and approaches in treating pancreatic cancer. Additional emphasis is placed on the study of nanoparticle-based delivery systems, with a brief mention of those in clinical trials. Overall, the overview illustrates the significant advances in nanomedicine, underscoring its role in transcending the constraints of conventional PDAC therapies and diagnostics.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gu, X., & Minko, T. (2024). Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer. Cancers, 16(8), 1589. https://doi.org/10.3390/cancers16081589
MLA 9
Gu, Xin, and Tamara Minko. “Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer.” Cancers, vol. 16, no. 8, 2024, p. 1589. https://doi.org/10.3390/cancers16081589.
Chicago
Gu, Xin and Tamara Minko. 2024. “Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer.” Cancers 16 (8): 1589. https://doi.org/10.3390/cancers16081589.
Harvard
Gu, X. and Minko, T. (2024) ‘Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer’, Cancers, 16(8), p. 1589. doi:10.3390/cancers16081589.
IEEE
X. Gu and T. Minko, “Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer,” Cancers, vol. 16, no. 8, p. 1589, 2024, doi: 10.3390/cancers16081589.
BibTeX
@article{gu2024targeted,
title = {{Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer}},
author = {Gu, Xin and Minko, Tamara},
journal = {Cancers},
year = {2024},
volume = {16},
number = {8},
pages = {1589},
doi = {10.3390/cancers16081589},
url = {https://doi.org/10.3390/cancers16081589}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 11 | |
| 2025 | 31 | |
| 2026 | 30 |
Its field-weighted citation impact is 1.62: it has been cited 1.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic ductal adenocarcinoma
- pancreatic cancer
- nanoparticle drug delivery
- targeted drug delivery
- tumor stroma
- gemcitabine
- paclitaxel
- tumor-penetrating peptide
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Gu, X., & Minko, T. (2024). Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer. Cancers, 16(8), 1589. https://doi.org/10.3390/cancers16081589
How many times has this paper been cited?
72 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cancers: sign in and open the PDF from this page.
Who wrote this paper?
Xin Gu, Tamara Minko.
What is the DOI of this paper?
10.3390/cancers16081589, permanently at https://doi.org/10.3390/cancers16081589. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.